SLIDESHOW: Ten Bargains You Can Buy Cheaper Than The Insiders
This Slide: #1 of 10 |
(1) Summit Therapeutics Inc (NASDAQ:SMMT) triggered: 04/17/2024
Summit Therapeutics is holding company. Through its subsidiaries, Co. is a biopharmaceutical company focused on the discovery, development, and commercialization of medicinal therapies. Co.'s ivonescimab is a bispecific antibody that combines the benefits of immunotherapy via a blockade of PD-1 with the anti-angiogenesis benefits of an anti-vascular endothelial growth factor into a single molecule. Co. also focuses on ridinilazole, its product candidate for treating patients suffering from Clostridioides difficile infection. Co.'s other product candidate, SMT-738, is in development for combating multidrug resistant infections, specifically carbapenem-resistant Enterobacteriaceae infections.
SMMT — last trade: $3.86 — Recent Insider Buys:
Purchased | Insider | Title | Shares | Price/Share | Value |
---|---|---|---|---|---|
12/13/2023 | Ankur Dhingra | Chief Financial Officer | 20,400 | $2.17 | $44,254 |
12/12/2023 | Mahkam Zanganeh | Chief Executive Officer | 5,000 | $2.07 | $10,350 |
03/27/2024 | Mahkam Zanganeh | Chief Executive Officer | 110,321 | $3.73 | $411,094 |
03/26/2024 | Ankur Dhingra | Chief Financial Officer | 100,000 | $3.75 | $375,000 |
|
Read full article in a new window: Snatch This Deal Even Lower Than Chief Executive Officer Zanganeh Did
Open the SMMT Videos Page (in a new window) »
Free SMMT Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Strong Buy (4.00 out of 4) 81st percentile
(ranked higher than approx. 81% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |
|